Scarica l'app Stockscreener
62.49
2.13%
-1.36
Dopo l'orario di chiusura:
62.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$63.85
Aprire:
$63.59
Volume 24 ore:
432.15K
Relative Volume:
0.48
Capitalizzazione di mercato:
$3.15B
Reddito:
$1.36B
Utile/perdita netta:
$123.81M
Rapporto P/E:
25.93
EPS:
2.41
Flusso di cassa netto:
$20.35M
1 W Prestazione:
-0.24%
1M Prestazione:
+2.64%
6M Prestazione:
-16.66%
1 anno Prestazione:
-33.80%
Intervallo 1D:
$62.45
$64.00
Intervallo di 1 settimana:
$61.81
$64.42
Portata 52W:
$55.30
$97.97
Haemonetics Corp Stock (HAE) Company Profile
Nome
Haemonetics Corp
Settore
Industria
Telefono
(781) 848-7100
Indirizzo
125 SUMMER STREET, BOSTON, MA
Confronta HAE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
62.49 | 3.15B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-07 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Iniziato | JP Morgan | Overweight |
| 2024-11-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Iniziato | CL King | Buy |
| 2024-09-11 | Iniziato | BofA Securities | Neutral |
| 2024-09-10 | Iniziato | BTIG Research | Buy |
| 2024-06-12 | Aggiornamento | Needham | Hold → Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-01-27 | Downgrade | Needham | Buy → Hold |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Ripresa | Raymond James | Outperform |
| 2021-06-17 | Iniziato | Citigroup | Buy |
| 2021-05-14 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Iniziato | Needham | Buy |
| 2019-08-07 | Reiterato | Barrington Research | Outperform |
| 2019-05-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Reiterato | Barrington Research | Outperform |
| 2018-08-09 | Reiterato | Barrington Research | Outperform |
| 2018-02-07 | Reiterato | Barrington Research | Outperform |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Reiterato | Barrington Research | Outperform |
| 2017-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Reiterato | The Benchmark Company | Hold |
| 2016-09-20 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Downgrade | Sidoti | Buy → Neutral |
| 2016-08-02 | Reiterato | Jefferies | Buy |
| 2016-08-02 | Reiterato | The Benchmark Company | Hold |
Mostra tutto
Haemonetics Corp Borsa (HAE) Ultime notizie
Haemonetics (HAE) Expected to Announce Quarterly Earnings on Thursday - Defense World
BofA Securities’s latest rating for HAE stock - knoxdaily.com
Taking on analysts’ expectations and winning: Haemonetics Corp (HAE) - Sete News
How Do Investors Really Feel About Haemonetics?Haemonetics (NYSE:HAE) - Benzinga
Bank of Montreal Can Sells 12,518,398 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Cerity Partners LLC Decreases Stock Position in Haemonetics Co. (NYSE:HAE) - Defense World
Reviewing Haemonetics (NYSE:HAE) and Apyx Medical (NASDAQ:APYX) - Defense World
Is Haemonetics Corporation (HAE) the Best Russell 2000 Stock to Buy According to Wall Street Analysts? - Insider Monkey
Patient Blood Management Market is Set to Experience - openPR.com
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know - Yahoo Finance
Haemonetics stock touches 52-week low at $58.24 amid challenges By Investing.com - Investing.com South Africa
Haemonetics stock touches 52-week low at $58.24 amid challenges - Investing.com Australia
Q4 Earnings Highs And Lows: Haemonetics (NYSE:HAE) Vs The Rest Of The Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
Vanguard Group Inc. Purchases 10,119 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Prudential Financial Inc. Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - Defense World
HighTower Advisors LLC Buys 244 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
3 Reasons to Avoid HAE and 1 Stock to Buy Instead - Yahoo Finance
Haemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now? - Insider Monkey
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
10 Pro-Life Companies to Invest In Now - Insider Monkey
A Note On Haemonetics Corporation's (NYSE:HAE) ROE and Debt To Equity - Yahoo Finance
Fractional Flow Reserve Market Set for 11.27% CAGR Growth by 2031 - openPR
Haemonetics (NYSE:HAE) Given New $104.00 Price Target at Needham & Company LLC - Defense World
Is it Apt to Retain HAE Stock in Your Portfolio for Now? - Nasdaq
Demystifying Haemonetics: Insights From 5 Analyst Reviews - Nasdaq
Needham Trims Price Target on Haemonetics to $104 From $108, Keeps Buy Rating -March 18, 2025 at 06:53 am EDT - MarketScreener
Haemonetics FY2025 EPS Estimate Reduced by Zacks Research - Defense World
Raymond James Financial Inc. Takes Position in Haemonetics Co. (NYSE:HAE) - Defense World
Haemonetics Corp (HAE) Shares Down 3.63% on Mar 12 - GuruFocus.com
Haemonetics at Raymond James Conference: Strategic Growth Insights - Investing.com
Haemonetics at Raymond James Conference: Strategic Growth Insights By Investing.com - Investing.com UK
Haemonetics Names Chief Operating Officer, Chief Commercial Officer -March 03, 2025 at 05:40 pm EST - Marketscreener.com
Haemonetics appoints new executive leadershi - Investing.com
Haemonetics Announces Executive Leadership Updates - Quantisnow
Global Blood Bank Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight - GlobeNewswire Inc.
Haemonetics Corp. to Host Earnings Call - ACCESS Newswire
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Quantisnow
Zacks Research Forecasts Haemonetics’ Q3 Earnings (NYSE:HAE) - Defense World
Van ECK Associates Corp Buys Shares of 39,620 Haemonetics Co. (NYSE:HAE) - Defense World
Haemonetics FY2025 EPS Forecast Decreased by Zacks Research - Defense World
(HAE)Analyzing Haemonetics's Short Interest - Benzinga
SG Americas Securities LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Janney Montgomery Scott LLC Invests $402,000 in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Reaches New 12-Month Low After Analyst Downgrade - MarketBeat
Haemonetics Co. (NYSE:HAE) Given Consensus Rating of “Moderate Buy” by Brokerages - Armenian Reporter
Haemonetics Co. (NYSE:HAE) Shares Sold by Retirement Systems of Alabama - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Sold by Yousif Capital Management LLC - Defense World
Haemonetics' (NYSE:HAE) Earnings Offer More Than Meets The Eye - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Receives $101.67 Average Price Target from Analysts - MarketBeat
Haemonetics (NYSE:HAE) Given New $108.00 Price Target at Needham & Company LLC - MarketBeat
Haemonetics Corp Azioni (HAE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
11.62%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):